Strategies to Maintain Cardiac Risk Control After Discharge From Cardiovascular Risk Reduction Clinic

Completed · Phase 3

Conditions studied: Diabetes, Dyslipidemia, Hypertension, Coronary Atherosclerosis

In brief

The purpose of this study is to determine whether a combined behavioral and pharmacological intervention provided by a multidisciplinary team will further reduce LDL-C, smoking, BP and Hb-A1C in diabetic patients with A1c between 7% and 9% when compared to usual care.

Key facts

Study ID

NCT00358033

Run by

Providence VA Medical Center

People needed

200

Starts

2003-07-01

Expected to finish

2008-05-01

Last updated by the study team

2014-04-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Previous enrollment in Cardiovascular Risk Reduction Clinic (CRRC)
• Eligible for CRRC discharge:
• For DM patients:
• HbA1c < 7.0 %,
• BP < 130/85 mm Hg , and
• LDL < 100 mg/dl;
• For Non-DM patients:
• BP < 140/90 mm Hg, and
• LDL < 100 mg/dl;
• Able and willing to sign informed consent.

You may not qualify if…

• Presence of conditions that might limit long-term compliance (eg, dementia, acute psychiatric decompensation within the previous 6 months, unstable psychiatric disorder);
• Metastatic disease or terminal illness

Where it is running

• Providence VAMC — Providence, Rhode Island, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.